One shot to stop cancer? major trial tests simpler HPV vaccine
NCT ID NCT05237947
Summary
This study is testing if just one dose of the HPV vaccine can effectively prevent cervical cancer in young women. It involves 5,000 women in Costa Rica aged 18-30 who have not been vaccinated before. Participants receive either one dose of an HPV vaccine or a control vaccine, and researchers will track them for years to see if the single shot prevents long-term HPV infections that can lead to cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Agencia Costarricense de Investigaciones Biomédicas (ACIB)
Liberia, Guanacaste Province, 50101, Costa Rica
Conditions
Explore the condition pages connected to this study.